West Pharmaceutical Services (WST)
SG&A Expense Growth
18.19%
Quarterly · Period ending:
WST SG&A Expense Growth
Latest reported18.19%period ending
Latest reported18.19%period ending
WST Quarterly SG&A Growth (QoQ) (0.00% → 18.19%)
Latest values, visible window
High-resolution chart · PNG
WST sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -1.5544% | |
| 14.881% | |
| 1.8182% | |
| -2.9412% | |
| -2.2989% | |
| -20.9091% | |
| 14.5833% | |
| -2.5381% | |
| 15.8824% | |
| -5.5556% | |
| 4.0462% | |
| -5.9783% | |
| 9.5238% | |
| 0% | |
| 3.0675% | |
| -14.6597% | |
| 6.1111% | |
| 2.8571% | |
| -3.3149% | |
| 0% | |
| -5.2356% | |
| 6.1111% | |
| 8.4337% | |
| -8.2873% | |
| 7.7381% | |
| -20% | |
| 34.6154% | |
| -7.6923% | |
| 9.0323% | |
| -12.4294% | |
| 17.2185% | |
| -4.4304% | |
| 6.0403% | |
| -6.875% | |
| 11.8881% | |
| 3.6232% | |
| 6.1538% | |
| -71.1752% | |
| 266.6667% | |
| -10.219% | |
| -1.4388% | |
| -29.0816% | |
| 66.1017% | |
| -11.9403% | |
| 3.0769% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |